It’s also strange indeed that Biotron favoured the HIV trial analysis first over the Covid analysis. One would think a few extra months won’t worry HiV, but Covid, (and antivirals in general) are immediate, in fact 4 years late yet people still think the Covid results are what’s going to save the company.
Complete headline results for Commercial Deal, when?, page-59
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1549 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 2535 | 1 |
View Market Depth
| Last trade - 07.04am 22/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |
Day chart unavailable